Pipeline Insight: HIV - Extending Treatment Options
Topics: AIDS, HIV & STDs, Research & Development, Drug Discovery
|
Antiviral Therapeutics: Pipelines and Competitive Dynamics
Topics: AIDS, HIV & STDs
|
Latin American Rapid Test Markets for Infectious Diseases
Topics: AIDS, HIV & STDs, Immunoassays, Diagnostics
Regions: South America
|
Executive Summary: HIV: A Strategic Analysis of Therapeutic and Testing Markets
Topics: AIDS, HIV & STDs
|
Securing a Competitive Advantage in the Reverse Transcriptase Market
Topics: Molecular Biology, AIDS, HIV & STDs
|
HIV: A Strategic Analysis of Therapeutic and Testing Markets
Topics: In Vitro Diagnostics, AIDS, HIV & STDs
|
Pharmaceuticals and Politics: Will Political Opinion Affect the Future of HPV Vaccines?
Topics: AIDS, HIV & STDs, General Pharmaceuticals, Regulation & Policy, Women's Health
|
Stakeholder Opinions: Sexually Transmitted Infections - The Silent Menace
Topics: AIDS, HIV & STDs
|
Commercial Insight: Herpes and Respiratory Antivirals - Leaders Rise and Fall
Topics: AIDS, HIV & STDs, Vaccines
|
Stakeholder Insight: HIV - A way of life
Topics: AIDS, HIV & STDs
|
HIV Diagnostics: Key Disease Management Role Spells Opportunity
Topics: AIDS, HIV & STDs, Disease Management
|
Commercial Insight: HIV - Simplicity and Survival
Topics: AIDS, HIV & STDs
|
Pipeline Insight: HIV - Hold Your Horses
Topics: AIDS, HIV & STDs
|
Rapid Viral Testing
Topics: AIDS, HIV & STDs, Research & Development
|
Strategic Analysis of Global HIV Diagnostics and Monitoring Markets
Topics: AIDS, HIV & STDs
|
Stakeholder Opinions: HIV Vaccines - The Emperor Has No Clothes
Topics: AIDS, HIV & STDs, Vaccines
|
Pandemic Control: Resistant Organisms and Emerging Threats
Topics: AIDS, HIV & STDs, Public Health, Prescription Drugs
|
Commercial Insight: HIV - From the Naïve to the Complex
Topics: AIDS, HIV & STDs
|
Stakeholder Insight: HIV Related Neuropathic Pain - Useful Niche for Peripheral Companies
Topics: Pain, AIDS, HIV & STDs
|
Pipeline Insight: HIV - Enter the New Generation Inhibitors
Topics: AIDS, HIV & STDs
|
Stakeholder Opinions: HIV/ HBV Co-infection - More Potency, More Policy
Topics: AIDS, HIV & STDs
|
HIV Resistance: Impact and Evolution
Topics: AIDS, HIV & STDs
|
Stakeholder Opinions: HIV - Reaching the 'Untapped' Patient Population
Topics: AIDS, HIV & STDs
|
Stakeholder Opinions: HIV/HCV Co-infection - Whose Niche?
Topics: AIDS, HIV & STDs
|
Commercial Insight: HIV in the USA - Increasing Choice, Flexibility and Competition
Topics: AIDS, HIV & STDs
Regions: United States
|
U.S. Infectious Diseases: Sexually Transmitted Disease Diagnostics Markets
Topics: AIDS, HIV & STDs, Diseases & Conditions
Regions: United States
|
HIV Update 2002 (11) - November
Topics: AIDS, HIV & STDs
|
HIV Update 2003 (3) - March
Topics: AIDS, HIV & STDs
|
HIV Update 2003 (1) - January
Topics: AIDS, HIV & STDs
|
HIV Update 2003 (2) - February
Topics: AIDS, HIV & STDs
|
HIV Update 2002 (12) - December
Topics: AIDS, HIV & STDs
|
HIV Pricing Strategies in the US and UK
Topics: AIDS, HIV & STDs
Regions: United Kingdom, United States
|
Drugs of Tomorrow: HIV - Managing Portfolio Growth During Sector Slowdown
Topics: AIDS, HIV & STDs
Regions: United States
|
PharmaWatch: Immune Disorders & Inflammation: February 2003
Topics: AIDS, HIV & STDs, Allergy/Immunology
|
U.S. HIV/AIDS Therapies Markets
Topics: AIDS, HIV & STDs
Regions: United States
|
U.S. HIV Diagnostics and Monitoring Markets
Topics: AIDS, HIV & STDs, Microbiology & Virology
Regions: United States
|
HIV Update 2002 (10) - October
Topics: AIDS, HIV & STDs
|
Treatment Algorithm: HIV 4th Edition - Current Treatment Strategies and Commercial Imperatives
Topics: AIDS, HIV & STDs
|
HIV Update 2002 (8) - August
Topics: AIDS, HIV & STDs
|
HIV Update 2002 (9) - September
Topics: AIDS, HIV & STDs
|
Primary Immune Deficiencies - An Overview
Topics: AIDS, HIV & STDs, Blood Supply, Tissue Banking, Transplantation
|
HIV Update 2002 (6): June
Topics: AIDS, HIV & STDs
|
HIV Update 2002 (7): July
Topics: AIDS, HIV & STDs
|
The XIV International AIDS Conference 2002
Topics: AIDS, HIV & STDs
Regions: Global
|
The HIV Pipeline - A Complete Overview
Topics: AIDS, HIV & STDs
|
Strategic Perspectives: Opportunistic Infections in HIV - Will HAART Be Enough?
Topics: AIDS, HIV & STDs, Infectious Diseases
|
HIV Update 2002 (5) - May
Topics: AIDS, HIV & STDs
|
HIV Update 2002 (4) - April
Topics: AIDS, HIV & STDs
|
HIV Update 2002 (3) - March
Topics: AIDS, HIV & STDs, Infectious Diseases
|
HIV Update 2002 (2) - February
Topics: AIDS, HIV & STDs, Infectious Diseases
|
